Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-21 Sale |
2023-04-25 9:39 pm |
Ventyx Biosciences Inc. | VTYX | NSV Partners III LP NSV Partners III GP LLC 10% Owner |
100,000 | $38.54 | $3,853,993 | 9,877,045 (Indirect) |
View |
| 2023-04-21 Sale |
2023-04-25 9:38 pm |
Ventyx Biosciences Inc. | VTYX | Subramaniam Somu Director 10% Owner |
100,000 | $38.54 | $3,853,993 | 9,877,045 (Indirect) |
View |
| 2023-04-17 Sale |
2023-04-19 4:51 pm |
Ventyx Biosciences Inc. | VTYX | Auster Martin Chief Financial Officer |
7,000 | $33 | $231,013 | 350,833 (Direct) |
View |
| 2023-04-12 Sale |
2023-04-14 6:35 pm |
Ventyx Biosciences Inc. | VTYX | Subramaniam Somu Director 10% Owner |
100,000 | $30.23 | $3,022,665 | 9,977,045 (Indirect) |
View |
| 2023-04-12 Sale |
2023-04-14 6:33 pm |
Ventyx Biosciences Inc. | VTYX | NSV Partners III LP NSV Partners III GP LLC 10% Owner |
100,000 | $30.23 | $3,022,665 | 9,977,045 (Indirect) |
View |
| 2023-04-10 Sale |
2023-04-12 4:58 pm |
Ventyx Biosciences Inc. | VTYX | Mohan Raju Chief Executive Officer |
9,255 | $29.01 | $268,519 | 1,573,126 (Direct) |
View |
| 2023-04-05 Sale |
2023-04-07 3:47 pm |
Ventyx Biosciences Inc. | VTYX | Mohan Raju Chief Executive Officer |
20,745 | $29.52 | $612,401 | 1,582,381 (Direct) |
View |
| 2023-04-04 Sale |
2023-04-05 7:18 pm |
Ventyx Biosciences Inc. | VTYX | Auster Martin Chief Financial Officer |
21,000 | $30.76 | $646,035 | 357,833 (Direct) |
View |
| 2022-04-03 Sale |
2023-04-05 7:16 pm |
Ventyx Biosciences Inc. | VTYX | Krueger Christopher W Chief Business Officer |
15,000 | $32.88 | $493,165 | 446,293 (Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 7:13 pm |
Ventyx Biosciences Inc. | VTYX | Nuss John Chief Scientific Officer |
30,000 | $32.87 | $986,233 | 311,593 (Direct) |
View |
| 2023-03-30 Sale |
2023-03-31 4:46 pm |
Ventyx Biosciences Inc. | VTYX | Gujrathi Sheila Director |
100,000 | $33.73 | $3,373,240 | 662,369 (Direct) |
View |
| 2023-01-23 Sale |
2023-01-24 6:33 pm |
Ventyx Biosciences Inc. | VTYX | White William Richard Director |
33,353 | $35.1 | $1,170,592 | 119,120 (Direct) |
View |
| 2022-12-22 Sale |
2022-12-23 6:35 pm |
Ventyx Biosciences Inc. | VTYX | Mohan Raju Chief Executive Officer |
55,354 | $31.61 | $1,749,640 | 1,603,126 (Direct) |
View |
| 2022-12-22 Sale |
2022-12-23 6:33 pm |
Ventyx Biosciences Inc. | VTYX | Nuss John Chief Scientific Officer |
13,812 | $31.61 | $436,654 | 244,815 (Direct) |
View |
| 2022-12-22 Sale |
2022-12-23 6:32 pm |
Ventyx Biosciences Inc. | VTYX | Krueger Christopher W Chief Business Officer |
3,654 | $31.61 | $115,518 | 282,670 (Direct) |
View |
| 2022-12-15 Sale |
2022-12-19 6:56 pm |
Ventyx Biosciences Inc. | VTYX | NSV Partners III LP NSV Partners III GP LLC 10% Owner |
300,000 | $33.28 | $9,985,024 | 12,974,786 (Indirect) |
View |
| 2022-12-15 Sale |
2022-12-19 6:55 pm |
Ventyx Biosciences Inc. | VTYX | Subramaniam Somu Director 10% Owner |
300,000 | $33.28 | $9,985,024 | 12,974,786 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-11 Option Award(A) |
2023-04-26 8:31 pm |
N/A 2033-01-11 |
Ventyx Biosciences Inc. | VTYX | HULME ALLISON Director |
20,427 | $0 | 20,427 (Direct) |
View |
| 2022-06-09 Option Award(A) |
2023-04-26 8:31 pm |
N/A 2032-06-09 |
Ventyx Biosciences Inc. | VTYX | Subramaniam Somu Director 10% Owner |
21,825 | $0 | 21,825 (Direct) |
View |
| 2022-06-09 Option Award(A) |
2023-04-26 8:30 pm |
N/A 2032-06-09 |
Ventyx Biosciences Inc. | VTYX | Gujrathi Sheila Director |
21,825 | $0 | 21,825 (Direct) |
View |
| 2022-06-09 Option Award(A) |
2023-04-26 8:27 pm |
N/A 2032-06-09 |
Ventyx Biosciences Inc. | VTYX | White William Richard Director |
21,825 | $0 | 21,825 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-19 4:51 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Auster Martin Chief Financial Officer |
7,000 | $3.45 | 350,833 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-19 4:51 pm |
N/A 2031-05-06 |
Ventyx Biosciences Inc. | VTYX | Auster Martin Chief Financial Officer |
7,000 | $0 | 350,833 (Direct) |
View |
| 2023-04-06 Other |
2023-04-10 9:11 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Subramaniam Somu Director 10% Owner |
1,747,098 | $0 | 11,824,143 (Indirect) |
View |
| 2023-04-06 Other |
2023-04-10 9:09 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | NSV Partners III LP NSV Partners III GP LLC 10% Owner |
1,747,098 | $0 | 11,824,143 (Indirect) |
View |
| 2023-04-04 Exercise |
2023-04-05 7:18 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Auster Martin Chief Financial Officer |
21,000 | $3.45 | 357,833 (Direct) |
View |
| 2023-04-04 Exercise |
2023-04-05 7:18 pm |
N/A 2031-05-06 |
Ventyx Biosciences Inc. | VTYX | Auster Martin Chief Financial Officer |
21,000 | $0 | 357,833 (Direct) |
View |
| 2022-04-03 Exercise |
2023-04-05 7:16 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Krueger Christopher W Chief Business Officer |
7,972 | $3.54 | 446,293 (Direct) |
View |
| 2022-04-03 Exercise |
2023-04-05 7:16 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Krueger Christopher W Chief Business Officer |
475 | $8.04 | 446,293 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 7:16 pm |
2021-02-26 2031-02-26 |
Ventyx Biosciences Inc. | VTYX | Krueger Christopher W Chief Business Officer |
8,447 | $0 | 446,293 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 7:13 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Nuss John Chief Scientific Officer |
30,000 | $0.2 | 311,593 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 7:13 pm |
N/A 2030-05-01 |
Ventyx Biosciences Inc. | VTYX | Nuss John Chief Scientific Officer |
30,000 | $0 | 311,593 (Direct) |
View |
| 2023-03-30 Exercise |
2023-03-31 4:46 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Gujrathi Sheila Director |
100,000 | $6.03 | 662,369 (Direct) |
View |
| 2023-03-30 Exercise |
2023-03-31 4:46 pm |
N/A 2031-08-17 |
Ventyx Biosciences Inc. | VTYX | Gujrathi Sheila Director |
100,000 | $0 | 662,369 (Direct) |
View |
| 2023-03-17 Other |
2023-03-21 6:13 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Subramaniam Somu Director 10% Owner |
591,276 | $0 | 12,415,419 (Indirect) |
View |
| 2023-03-17 Other |
2023-03-21 6:10 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | NSV Partners III LP NSV Partners III GP LLC 10% Owner |
591,276 | $0 | 12,415,419 (Indirect) |
View |
| 2023-03-03 Other |
2023-03-07 8:51 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | NSV Partners III LP NSV Partners III GP LLC 10% Owner |
559,367 | $0 | 12,974,786 (Indirect) |
View |
| 2023-03-03 Other |
2023-03-07 8:48 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Subramaniam Somu Director 10% Owner |
559,367 | $0 | 12,974,786 (Indirect) |
View |
| 2022-12-21 Ownership |
2023-02-13 7:10 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Gujrathi Sheila Director |
32,987 | $0 | 0 (Direct) |
View |
| 2023-01-23 Exercise |
2023-01-24 6:33 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | White William Richard Director |
33,353 | $6.03 | 119,120 (Direct) |
View |
| 2023-01-23 Exercise |
2023-01-24 6:33 pm |
N/A 2031-08-17 |
Ventyx Biosciences Inc. | VTYX | White William Richard Director |
33,353 | $0 | 119,120 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-18 8:36 pm |
N/A 2033-01-17 |
Ventyx Biosciences Inc. | VTYX | Krueger Christopher W Chief Business Officer |
126,875 | $0 | 126,875 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-18 8:34 pm |
N/A 2033-01-17 |
Ventyx Biosciences Inc. | VTYX | Auster Martin Chief Financial Officer |
126,875 | $0 | 126,875 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-18 8:32 pm |
N/A 2033-01-17 |
Ventyx Biosciences Inc. | VTYX | Sandborn William J. See Remarks |
140,000 | $0 | 140,000 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-18 8:27 pm |
N/A 2033-01-17 |
Ventyx Biosciences Inc. | VTYX | Mohan Raju Chief Executive Officer |
331,625 | $0 | 331,625 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-18 8:24 pm |
N/A 2033-01-17 |
Ventyx Biosciences Inc. | VTYX | Nuss John Chief Scientific Officer |
126,875 | $0 | 126,875 (Direct) |
View |
| 2023-01-11 Option Award |
2023-01-12 5:13 pm |
N/A 2033-01-11 |
Ventyx Biosciences Inc. | VTYX | Cadoret-Manier Onaiza Director |
12,880 | $0 | 12,880 (Direct) |
View |
| 2023-01-11 Option Award |
2023-01-12 5:11 pm |
N/A 2033-01-11 |
Ventyx Biosciences Inc. | VTYX | HULME ALLISON Director |
12,880 | $0 | 12,880 (Direct) |
View |
| 2022-12-17 Exercise |
2022-12-20 8:02 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Nuss John Chief Scientific Officer |
34,931 | $0 | 363,418 (Direct) |
View |
| 2022-12-17 Exercise |
2022-12-20 8:01 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Mohan Raju Chief Executive Officer |
116,669 | $0 | 2,008,484 (Direct) |
View |
| 2022-12-17 Exercise |
2022-12-20 7:57 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Krueger Christopher W Chief Business Officer |
10,480 | $0 | 317,761 (Direct) |
View |